CRL Annual FCF
$365.37 M
+$70.46 M+23.89%
30 December 2023
Summary:
As of January 20, 2025, CRL annual free cash flow is $365.37 million, with the most recent change of +$70.46 million (+23.89%) on December 30, 2023. During the last 3 years, it has fallen by -$14.64 million (-3.85%). CRL annual FCF is now -31.32% below its all-time high of $532.03 million, reached on December 25, 2021.CRL Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Quarterly FCF
$213.07 M
+$59.02 M+38.31%
28 September 2024
Summary:
As of January 20, 2025, CRL quarterly free cash flow is $213.07 million, with the most recent change of +$59.02 million (+38.31%) on September 28, 2024. Over the past year, it has increased by +$70.45 million (+49.40%). CRL quarterly FCF is now at all-time high.CRL Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL TTM FCF
$560.48 M
+$73.57 M+15.11%
28 September 2024
Summary:
As of January 20, 2025, CRL TTM free cash flow is $560.48 million, with the most recent change of +$73.57 million (+15.11%) on September 28, 2024. Over the past year, it has increased by +$195.11 million (+53.40%). CRL TTM FCF is now at all-time high.CRL TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRL Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +23.9% | +49.4% | +53.4% |
3 y3 years | -3.9% | +49.4% | +53.4% |
5 y5 years | +21.4% | +49.4% | +53.4% |
CRL Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -31.3% | +23.9% | at high | +8395.6% | at high | +103.6% |
5 y | 5-year | -31.3% | +23.9% | at high | +8395.6% | at high | +103.6% |
alltime | all time | -31.3% | +2202.6% | at high | +645.5% | at high | +3325.4% |
Charles River Laboratories International Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $213.07 M(+38.3%) | $560.48 M(+15.1%) |
June 2024 | - | $154.05 M(+203.6%) | $486.92 M(+17.7%) |
Mar 2024 | - | $50.74 M(-64.4%) | $413.61 M(+13.2%) |
Dec 2023 | $365.37 M(+23.9%) | $142.62 M(+2.2%) | $365.37 M(-0.8%) |
Sept 2023 | - | $139.50 M(+72.8%) | $368.48 M(+27.3%) |
June 2023 | - | $80.74 M(+3119.3%) | $289.37 M(+5.1%) |
Mar 2023 | - | $2.51 M(-98.3%) | $275.25 M(-6.7%) |
Dec 2022 | $294.91 M(-44.6%) | $145.73 M(+141.3%) | $294.91 M(+5.5%) |
Sept 2022 | - | $60.39 M(-9.4%) | $279.66 M(-17.4%) |
June 2022 | - | $66.62 M(+200.6%) | $338.46 M(-17.8%) |
Mar 2022 | - | $22.17 M(-83.0%) | $411.99 M(-22.6%) |
Dec 2021 | $532.03 M(+40.0%) | $130.48 M(+9.5%) | $532.03 M(+17.7%) |
Sept 2021 | - | $119.19 M(-15.0%) | $452.07 M(-6.6%) |
June 2021 | - | $140.16 M(-1.4%) | $484.00 M(+1.0%) |
Mar 2021 | - | $142.20 M(+181.4%) | $479.35 M(+26.1%) |
Dec 2020 | $380.01 M(+11.6%) | $50.52 M(-66.6%) | $380.01 M(-14.9%) |
Sept 2020 | - | $151.12 M(+11.5%) | $446.33 M(+7.3%) |
June 2020 | - | $135.51 M(+216.1%) | $415.90 M(+8.0%) |
Mar 2020 | - | $42.87 M(-63.3%) | $385.16 M(+13.1%) |
Dec 2019 | $340.42 M(+13.1%) | $116.84 M(-3.2%) | $340.42 M(+15.4%) |
Sept 2019 | - | $120.68 M(+15.2%) | $294.88 M(+9.6%) |
June 2019 | - | $104.77 M(-5696.8%) | $269.00 M(+0.8%) |
Mar 2019 | - | -$1.87 M(-102.6%) | $266.89 M(-11.4%) |
Dec 2018 | $301.09 M(+27.8%) | $71.30 M(-24.8%) | $301.09 M(-7.5%) |
Sept 2018 | - | $94.81 M(-7.7%) | $325.52 M(+21.4%) |
June 2018 | - | $102.66 M(+217.6%) | $268.19 M(+7.1%) |
Mar 2018 | - | $32.33 M(-66.2%) | $250.33 M(+6.2%) |
Dec 2017 | $235.64 M(-9.9%) | $95.73 M(+155.5%) | $235.64 M(+0.6%) |
Sept 2017 | - | $37.47 M(-55.8%) | $234.31 M(-9.5%) |
June 2017 | - | $84.80 M(+380.8%) | $258.91 M(+6.9%) |
Mar 2017 | - | $17.64 M(-81.3%) | $242.14 M(-7.4%) |
Dec 2016 | $261.61 M(+8.2%) | $94.40 M(+52.1%) | $261.61 M(+0.9%) |
Sept 2016 | - | $62.08 M(-8.7%) | $259.29 M(-5.6%) |
June 2016 | - | $68.03 M(+83.3%) | $274.71 M(-1.4%) |
Mar 2016 | - | $37.10 M(-59.7%) | $278.52 M(+15.2%) |
Dec 2015 | $241.71 M(+24.5%) | $92.08 M(+18.8%) | $241.71 M(+8.9%) |
Sept 2015 | - | $77.50 M(+7.9%) | $221.94 M(+9.9%) |
June 2015 | - | $71.83 M(>+9900.0%) | $202.00 M(+13.6%) |
Mar 2015 | - | $288.00 K(-99.6%) | $177.81 M(-8.4%) |
Dec 2014 | $194.13 M(+15.6%) | $72.32 M(+25.6%) | $194.13 M(+14.1%) |
Sept 2014 | - | $57.56 M(+20.8%) | $170.09 M(-0.2%) |
June 2014 | - | $47.63 M(+186.8%) | $170.46 M(+5.8%) |
Mar 2014 | - | $16.61 M(-65.6%) | $161.05 M(-4.1%) |
Dec 2013 | $167.99 M(+4.8%) | $48.29 M(-16.6%) | $167.99 M(-1.5%) |
Sept 2013 | - | $57.92 M(+51.5%) | $170.47 M(+4.5%) |
June 2013 | - | $38.23 M(+62.4%) | $163.14 M(-5.6%) |
Mar 2013 | - | $23.55 M(-53.6%) | $172.75 M(+7.7%) |
Dec 2012 | $160.37 M | $50.77 M(+0.4%) | $160.37 M(+4.0%) |
Sept 2012 | - | $50.59 M(+5.8%) | $154.16 M(+7.3%) |
June 2012 | - | $47.84 M(+328.5%) | $143.64 M(-6.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $11.16 M(-74.9%) | $152.74 M(-2.2%) |
Dec 2011 | $156.14 M(+23.8%) | $44.57 M(+11.2%) | $156.14 M(-4.3%) |
Sept 2011 | - | $40.07 M(-29.6%) | $163.15 M(+24.0%) |
June 2011 | - | $56.93 M(+290.9%) | $131.58 M(+8.2%) |
Mar 2011 | - | $14.57 M(-71.8%) | $121.55 M(-3.6%) |
Dec 2010 | $126.15 M(-13.1%) | $51.58 M(+507.0%) | $126.15 M(+4.8%) |
Sept 2010 | - | $8.50 M(-81.9%) | $120.40 M(-19.2%) |
June 2010 | - | $46.91 M(+144.7%) | $149.03 M(-1.9%) |
Mar 2010 | - | $19.17 M(-58.2%) | $151.87 M(+4.6%) |
Dec 2009 | $145.19 M(+75.2%) | $45.83 M(+23.5%) | $145.19 M(+5.8%) |
Sept 2009 | - | $37.12 M(-25.4%) | $137.29 M(+10.9%) |
June 2009 | - | $49.75 M(+298.3%) | $123.83 M(+18.7%) |
Mar 2009 | - | $12.49 M(-67.1%) | $104.30 M(+25.9%) |
Dec 2008 | $82.87 M(+44.8%) | $37.93 M(+60.3%) | $82.87 M(+16.0%) |
Sept 2008 | - | $23.66 M(-21.7%) | $71.41 M(-4.3%) |
June 2008 | - | $30.22 M(-437.8%) | $74.59 M(+50.1%) |
Mar 2008 | - | -$8.95 M(-133.8%) | $49.70 M(-13.1%) |
Dec 2007 | $57.21 M(-429.2%) | $26.47 M(-1.4%) | $57.21 M(+939.1%) |
Sept 2007 | - | $26.84 M(+403.6%) | $5.51 M(-131.8%) |
June 2007 | - | $5.33 M(-471.4%) | -$17.34 M(-185.6%) |
Mar 2007 | - | -$1.44 M(-94.3%) | $20.25 M(-216.5%) |
Dec 2006 | -$17.38 M(-112.4%) | -$25.23 M(-731.0%) | -$17.38 M(-126.1%) |
Sept 2006 | - | $4.00 M(-90.7%) | $66.70 M(-24.5%) |
June 2006 | - | $42.92 M(-209.9%) | $88.31 M(+8.4%) |
Mar 2006 | - | -$39.06 M(-166.4%) | $81.49 M(-41.8%) |
Dec 2005 | $140.03 M(-0.0%) | $58.84 M(+129.8%) | $140.03 M(+5.1%) |
Sept 2005 | - | $25.60 M(-29.1%) | $133.22 M(-4.4%) |
June 2005 | - | $36.10 M(+85.3%) | $139.35 M(+0.8%) |
Mar 2005 | - | $19.48 M(-62.6%) | $138.25 M(-1.3%) |
Dec 2004 | $140.09 M(+53.8%) | $52.04 M(+64.0%) | $140.09 M(+22.4%) |
Sept 2004 | - | $31.73 M(-9.3%) | $114.41 M(+1.7%) |
June 2004 | - | $34.99 M(+64.1%) | $112.54 M(+3.6%) |
Mar 2004 | - | $21.33 M(-19.1%) | $108.62 M(+19.3%) |
Dec 2003 | $91.06 M(-5.3%) | $26.36 M(-11.7%) | $91.06 M(-2.5%) |
Sept 2003 | - | $29.86 M(-3.9%) | $93.44 M(+1.9%) |
June 2003 | - | $31.08 M(+724.7%) | $91.68 M(-5.5%) |
Mar 2003 | - | $3.77 M(-86.9%) | $97.00 M(+0.9%) |
Dec 2002 | $96.12 M(+177.5%) | $28.74 M(+2.3%) | $96.12 M(+10.0%) |
Sept 2002 | - | $28.09 M(-22.8%) | $87.35 M(+29.9%) |
June 2002 | - | $36.41 M(+1164.5%) | $67.27 M(+98.2%) |
Mar 2002 | - | $2.88 M(-85.6%) | $33.95 M(-2.0%) |
Dec 2001 | $34.64 M(+90.3%) | $19.98 M(+149.3%) | $34.64 M(+68.6%) |
Sept 2001 | - | $8.01 M(+160.0%) | $20.55 M(-14.1%) |
June 2001 | - | $3.08 M(-13.8%) | $23.92 M(+5.4%) |
Mar 2001 | - | $3.58 M(-39.2%) | $22.70 M(+24.7%) |
Dec 2000 | $18.20 M(-26.1%) | $5.88 M(-48.3%) | $18.20 M(+47.8%) |
Sept 2000 | - | $11.38 M(+512.1%) | $12.32 M(+1217.6%) |
June 2000 | - | $1.86 M(-301.1%) | $935.00 K(-201.1%) |
Mar 2000 | - | -$925.00 K | -$925.00 K |
Dec 1999 | $24.62 M(-3.4%) | - | - |
Dec 1998 | $25.47 M | - | - |
FAQ
- What is Charles River Laboratories International annual free cash flow?
- What is the all time high annual FCF for Charles River Laboratories International?
- What is Charles River Laboratories International annual FCF year-on-year change?
- What is Charles River Laboratories International quarterly free cash flow?
- What is the all time high quarterly FCF for Charles River Laboratories International?
- What is Charles River Laboratories International quarterly FCF year-on-year change?
- What is Charles River Laboratories International TTM free cash flow?
- What is the all time high TTM FCF for Charles River Laboratories International?
- What is Charles River Laboratories International TTM FCF year-on-year change?
What is Charles River Laboratories International annual free cash flow?
The current annual FCF of CRL is $365.37 M
What is the all time high annual FCF for Charles River Laboratories International?
Charles River Laboratories International all-time high annual free cash flow is $532.03 M
What is Charles River Laboratories International annual FCF year-on-year change?
Over the past year, CRL annual free cash flow has changed by +$70.46 M (+23.89%)
What is Charles River Laboratories International quarterly free cash flow?
The current quarterly FCF of CRL is $213.07 M
What is the all time high quarterly FCF for Charles River Laboratories International?
Charles River Laboratories International all-time high quarterly free cash flow is $213.07 M
What is Charles River Laboratories International quarterly FCF year-on-year change?
Over the past year, CRL quarterly free cash flow has changed by +$70.45 M (+49.40%)
What is Charles River Laboratories International TTM free cash flow?
The current TTM FCF of CRL is $560.48 M
What is the all time high TTM FCF for Charles River Laboratories International?
Charles River Laboratories International all-time high TTM free cash flow is $560.48 M
What is Charles River Laboratories International TTM FCF year-on-year change?
Over the past year, CRL TTM free cash flow has changed by +$195.11 M (+53.40%)